Naprod Life Sciences Pvt. Ltd.
bd_3489cd405053e988 · schema v1 · pii pii-v1
Full breach record for Naprod Life Sciences Pvt. Ltd. →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group LockBit 3.x on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Sanctions caution: LockBit 3.x carries US sanctions exposure — OFAC has designated the group or its operators. Public reporting is permitted (informational-materials exemption, 50 U.S.C. § 1702(b)(3)) — but any payment or material support may violate sanctions. Consult counsel before engaging.
Source: Ransomware.live
Post text · scraped from the leak site
A dream envisioned by Shri Babulal K. Jain in 1994, is now taking rapid strides in the Oncology market. Today Naprod Life Sciences is a dominant player in the Oncology and Anesthesia space not only in India but also globally. Naprod’s vision is to be...
Source provenance
- Source URL
- https://www.ransomware.live/id/bmFwcm9kZ3JvdXAuY29tQGxvY2tiaXQz
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Jun 4, 2024
- Raw hash
- 578b9928b2fa72fcf2e1eb3fbe10fb03ceb7aad1c0d497d1f18c15fa8f3ae3e0
Reporting entity
- Name
- lockbit3norm: lockbit_3
Victim entity
- Name
- Naprod Life Sciences Pvt. Ltd.norm: naprod life sciences pvt
- Domain
- naprodgroup.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· lockbit_3
- Threat actor
- LockBit 3.xExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.